Learn about Azilect: What is it used for, what you need to know before taking, important warnings and safety info, how to take, side effects and more. AZILECT (rasagiline tablets) is indicated for the treatment of Parkinson’s disease (PD). When AZILECT is prescribed as monotherapy or as adjunct therapy in patients not taking levodopa, patients may start AZILECT at the recommended dose of 1 mg administered orally once daily. Azilect (rasagiline) is an FDA-approved drug used to treat Parkinson's disease. Azilect (rasagiline) belongs to the MAO (monoamine oxidase inhibitor) drug class. Azilect works by increasing the levels of certain chemicals in the brain. Azilect is used to treat symptoms of Parkinson's disease (stiffness, tremors, spasms, poor muscle control). Azilect is sometimes used with another medicine called levodopa. Learn about rasagiline (Azilect) usage and dosing. Read the latest news and reviews about the drug as well as potential side effects and popular alternatives. Azilect (rasagiline) is a prescription tablet used to treat Parkinson’s disease. Learn about side effects, generic, cost, uses, dosage, and more. Rasagiline is used to treat symptoms of Parkinson's disease (stiffness, tremors, spasms, poor muscle control). Rasagiline is sometimes used with another medicine called levodopa. Rasagiline may also be used for purposes not listed in this medication guide. Find patient medical information for Rasagiline (Azilect) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings Azilect is an oral medication for Parkinson's disease that can be used alone or with other treatments. It works by blocking an enzyme called MAO-B, which helps increase and maintain dopamine levels in the brain, easing Parkinson's symptoms. Rasagiline, sold under the brand name Azilect among others, is a medication which is used in the treatment of Parkinson's disease. [2][6] It is used as a monotherapy to treat symptoms in early Parkinson's disease or as an adjunct therapy in more advanced cases. [7].